Generex Presents New Positive AE37 Phase II Breast Cancer Vaccine Data
Generex Biotechnology Corporation (OTC Bulletin Board: GNBT) announced two presentations of data obtained from its on-going Phase II trial of its novel immunotherapeutic AE37 vaccine in breast cancer patients...